Form D · Pharmaceuticals
Par Health, Inc.
St. Louis, MO · CIK 0002096530
Offering snapshot reported Nov 25, 2025 · SEC filing
- Reported sold
- $763M Offering amount: $763M
- Investors reported
- 234 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2025 | Initial | $763,000,000 | No comparison | 234 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-565058
Source: Form D, filed Nov 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Boyle | Executive |
| Andrew Gonce | Executive |
| Kass Harrold | Executive |
| Michael Heffernan | Director |
| Jake Longenecker | Executive |
| Matthew Maletta | Executive |
| Mick Mc Guinness | Executive |
| Joshua Murray | Director |
| Teresa Sanzottera | Executive |
| Scott Sims | Executive |
| Matthew Stober | Director |
| Stephen Welch | Director, Executive |
| Jeffrey Wiegers | Executive |
| Jonathan Zinman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
675 James S. Mc Donnell Blvd.
St. Louis, MO, 63042
Phone: 314-654-2000
St. Louis, MO, 63042
Phone: 314-654-2000